opportune 发表于 2025-3-26 21:23:42

http://reply.papertrans.cn/1/21/2058/2058-31.png

creditor 发表于 2025-3-27 03:45:49

Submitted on: 03 February 2012.
Revised on: 24 February 2012.
Accepted on: 01 April 2012.

___________________ANTIVIRAL THERAPY---SAGE PUBLICATIONS LTD

IRS 发表于 2025-3-27 05:52:15

Submitted on: 30 December 2024.
Revised on: 10 March 2025.
Accepted on: 01 April 2025.

___________________ANTIVIRAL THERAPY---SAGE PUBLICATIONS LTD

周年纪念日 发表于 2025-3-27 09:53:38

Submitted on: 06 December 2002.
Revised on: 21 March 2003.
Accepted on: 09 April 2003.

___________________ANTIVIRAL THERAPY---SAGE PUBLICATIONS LTD

Decrepit 发表于 2025-3-27 15:10:22

http://reply.papertrans.cn/1/21/2058/2058-35.png

Debate 发表于 2025-3-27 21:00:39

http://reply.papertrans.cn/1/21/2058/2058-36.png
页: 1 2 3 [4]
查看完整版本: SCIE期刊ANTIVIRAL THERAPY 2024/2025影响因子:1.335 (ANTIVIR THER) (1359-6535). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Citati